Lyon, France

Floriane Fusil

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Ecole Normale Superieure De Lyon, National Institute of Health and Medical Research. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Floriane Fusil: Innovator in Antibody Engineering

Introduction

Floriane Fusil is a prominent inventor based in Lyon, France. She has made significant contributions to the field of antibody engineering, particularly through her innovative patent related to lentiviral vectors. Her work has implications for therapeutic applications in immunology.

Latest Patents

Floriane Fusil holds a patent for a "Lentiviral vector expressing membrane-anchored or secreted antibody." This invention involves a multicistronic nucleic acid that enables the co-expression of sequences encoding both the light and heavy chain variable domains of an antibody. The patent details a complex structure that includes various coding sequences and splice sites, allowing for the production of separate proteins essential for antibody function. She has 1 patent to her name.

Career Highlights

Throughout her career, Floriane has worked at esteemed institutions such as University Claude Bernard - Lyon 1 and École Normale Supérieure de Lyon. Her research has focused on advancing the understanding of antibody structures and their applications in medicine.

Collaborations

Floriane has collaborated with notable researchers in her field, including Els Verhoeyen and François-Loïc Cosset. These partnerships have contributed to her innovative work and the advancement of antibody engineering.

Conclusion

Floriane Fusil is a trailblazer in the field of antibody engineering, with her patent showcasing her innovative approach to immunology. Her contributions continue to influence research and development in therapeutic applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…